Drug Discovery World

FEBRUARY 23, 2023

Kristen Hopson , Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yup Liu , Associate Director, HTS at Generate Biomedicines, reflect on the impact of AI, ML cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research.

Protein 52

Protein Life Science Bioassay Development 52

Drug Discovery World

SEPTEMBER 28, 2022

Ben Folwell, Principal Consultant at Citeline, maps out how AI, swarm learning and open access to clinical data could revolutionise drug discovery. . Artificial intelligence (AI) is notorious for its industry hype, touted to revolutionise the way multiple sectors operate over the next five to 10 years. The simple answer is no.

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

XTalks

JUNE 12, 2023

In August 2022, Medtronic acquired Affera , a company that develops and manufactures cardiac mapping and navigation systems as well as catheter-based cardiac ablation technologies. agreed to form a new, independent kidney care-focused medical device company ( NewCo ), in which they will have equal equity ownership.

FDA Approval 98

FDA Approval Production Sales In-Vitro 98